Latigo Biotherapeutics, Inc. (LTGO)

Latigo Biotherapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Latigo Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	42.37	69.63	17.92
Cash & Cash Equivalents	42.37	69.63	17.92
Cash Growth	-	288.60%	-
Other Current Assets	4.47	4.2	3.25
Total Current Assets	46.84	73.83	21.16
Property, Plant & Equipment	-	0.45	0.65
Goodwill and Intangibles	-	0.63	0.76
Other Long-Term Assets	-	0.62	0.29
Total Long-Term Assets	-	1.69	1.7
Total Assets	-	75.52	22.86
Accounts Payable	-	5.02	7.07
Current Debt	-	0.56	0.39
Other Current Liabilities	14.49	12.87	6.98
Total Current Liabilities	14.49	18.45	14.44
Long-Term Debt	-	0.13	0.46
Other Long-Term Liabilities	-	0.04	0.04
Total Long-Term Liabilities	-	0.16	0.5
Total Liabilities	-	18.61	14.93
Total Debt	0.55	0.69	0.85
Debt Growth	-	-18.92%	-
Retained Earnings	-	-243.13	-133.96
Shareholders' Equity	-252.58	-231.67	-129.6
Net Cash (Debt)	41.82	68.94	17.07
Net Cash (Debt) Growth	-	303.93%	-
Working Capital	32.35	55.38	6.73